Addressing Barriers to Palliative Care Use in Bladder Cancer
1 other identifier
observational
54
1 country
1
Brief Summary
Investigators plan to establish an in-depth understanding of knowledge and beliefs about palliative care in advanced Bladder Cancer patients and their caregivers, and to identify factors associated with positive and negative experiences with palliative care services among those who have received them.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 16, 2020
CompletedFirst Posted
Study publicly available on registry
October 22, 2020
CompletedStudy Start
First participant enrolled
December 22, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 10, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 10, 2021
CompletedJanuary 3, 2023
December 1, 2022
5 months
October 16, 2020
December 30, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Development of palliative care knowledge and beliefs
Thematic analysis of interviews transcriptions to identify the themes that underpin the development of palliative care beliefs among patients with muscle invasive bladder cancer.
12 Months
Proportion with accurate palliative care knowledge and beliefs
Proportion of patients correctly answering each palliative care knowledge question.
12 Months
Secondary Outcomes (1)
Association between Bladder Cancer stage and palliative care knowledge
12 Months
Study Arms (2)
Bladder Cancer Patient Participants
Participants will be scheduled for one-on-one interviews that will occur over Zoom or telephone.
Care Givers for Bladder Cancer Patient Participants
Participants will be scheduled for one-on-one interviews that will occur over Zoom or telephone.
Interventions
Survey will be administered involving questions regarding knowledge and perception of palliative care.
Eligibility Criteria
Bladder Cancer patient participants and care givers will be recruited from the Moffitt Cancer Genitourinary Oncology clinic and the Supportive Care clinic.
You may qualify if:
- Eligibility for both patient and caregiver participants will include:
- age ≥18 years
- able to speak and read English
- cognitively able to participate in study tasks
- willing to participate in surveys, semi-structured interviews, and/or focus groups
- able to participate in either a Zoom meeting or phone interview
- able to complete an emailed or paper survey
- Patient Participants: a diagnosis of muscle-invasive or locally advanced bladder cancer (stages II-IV).
You may not qualify if:
- Patients and caregivers will be excluded if unable to provide verbal or written consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Moffitt Cancer Center
Tampa, Florida, 33612, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Scott Gilbert, MD
Moffitt Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2020
First Posted
October 22, 2020
Study Start
December 22, 2020
Primary Completion
May 10, 2021
Study Completion
May 10, 2021
Last Updated
January 3, 2023
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share